Zydus Pharmaceuticals (USA) Inc. is recalling several lots of Clomipramine Hydrochloride capsules (25 mg, 50 mg, and 75 mg), a medication used to treat obsessive-compulsive disorder. The recall was initiated because testing detected an impurity called N-Nitroso Desmethyl-Clomipramine at levels that exceed the FDA's acceptable intake limit. Consumers should contact their healthcare provider or pharmacist regarding their medication use and can return the product for a refund.
The impurity, a type of nitrosamine (NDSRI), is classified as a probable human carcinogen, meaning long-term exposure above acceptable limits may increase the risk of cancer.
You have 2 options:
Manufactured for Northstar Rx LLC; Manufactured by Zydus Lifesciences Ltd., India; Recall #: D-0152-2026
Manufactured for Northstar Rx LLC; Manufactured by Zydus Lifesciences Ltd., India; Recall #: D-0153-2026
Manufactured for Northstar Rx LLC; Manufactured by Zydus Lifesciences Ltd., India; Recall #: D-0154-2026
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.